383 related articles for article (PubMed ID: 10856270)
1. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
[TBL] [Abstract][Full Text] [Related]
2. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ
Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225
[TBL] [Abstract][Full Text] [Related]
3. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.
Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ
Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of endogenous endothelin in patients with type II diabetes mellitus.
Cardillo C; Campia U; Bryant MB; Panza JA
Circulation; 2002 Oct; 106(14):1783-7. PubMed ID: 12356630
[TBL] [Abstract][Full Text] [Related]
6. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.
Mather KJ; Lteif A; Steinberg HO; Baron AD
Diabetes; 2004 Aug; 53(8):2060-6. PubMed ID: 15277386
[TBL] [Abstract][Full Text] [Related]
7. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
8. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
9. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats.
Granstam SO; Lind L; Granstam E; Fellström B
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958
[TBL] [Abstract][Full Text] [Related]
10. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.
Newby DE; Flint LL; Fox KA; Boon NA; Webb DJ
J Am Coll Cardiol; 1998 Jun; 31(7):1585-90. PubMed ID: 9626838
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelin in the increased vascular tone of patients with essential hypertension.
Cardillo C; Kilcoyne CM; Waclawiw M; Cannon RO; Panza JA
Hypertension; 1999 Feb; 33(2):753-8. PubMed ID: 10024340
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and endothelin in oxygen-dependent regulation of vascular tone of human umbilical vein.
Mildenberger E; Biesel B; Siegel G; Versmold HT
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1730-7. PubMed ID: 12969885
[TBL] [Abstract][Full Text] [Related]
13. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
[TBL] [Abstract][Full Text] [Related]
14. Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Blood Press; 1997 Sep; 6(5):279-85. PubMed ID: 9359998
[TBL] [Abstract][Full Text] [Related]
15. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
[TBL] [Abstract][Full Text] [Related]
16. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
17. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.
Cardillo C; Campia U; Kilcoyne CM; Bryant MB; Panza JA
Circulation; 2002 Jan; 105(4):452-6. PubMed ID: 11815427
[TBL] [Abstract][Full Text] [Related]
18. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C
J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172
[TBL] [Abstract][Full Text] [Related]
19. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers.
Kiowski W; Linder L; Stoschitzky K; Pfisterer M; Burckhardt D; Burkart F; Bühler FR
Circulation; 1994 Jul; 90(1):27-34. PubMed ID: 8026008
[TBL] [Abstract][Full Text] [Related]
20. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Cannan CR; Burnett JC; Brandt RR; Lerman A
Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]